Skip to content

The Effect of Periarticular Injection on Postoperative Intravenous Morphine Consumption and Functional Recovery in Combination with Continuous Femoral Nerve Block and Spinal Anesthesia with Small Dose Intrathecal Morphine in Patients undergoing Total Knee Arthroplasty : A Randomized, Single-Blind, Controlled Clinical Trial

The Effect of Periarticular Injection on Postoperative Intravenous Morphine Consumption and Functional Recovery in Combination with Continuous Femoral Nerve Block and Spinal Anesthesia with Small Dose Intrathecal Morphine in

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20150714002
Enrollment
40
Registered
2015-07-14
Start date
2015-10-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

unilateral total knee arthroplasty

Interventions

During intraoperative period&#44
before the cement is applied&#44
the periarticular injection with a mixture containing 10 ml of 0.5%levobupivacaine&#44
1 ml of 3%ketorolac&#44
0.2 ml of 0.2 ml of 0.1%epinephrine and 38.8 ml of 0.9%NaCl will be administered. For a total of 50 ml of this study drug&#44
30 ml will be injected into the posterior joint capsule and 20 ml will be injected around the lateral collateral ligament. ,The periarticular injection will not be administered in this group.
Experimental Drug,Placebo Comparator Drug
periarticular injection (PI),no periarticular injection (NPI)

Sponsors

Chaophraya Yommarat Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 75 Years

Inclusion criteria

Inclusion criteria: - ASA physical status I-III - Age 20-75 years old - Body weight ≥45 kgs.

Exclusion criteria

Exclusion criteria: - unable to evaluate visual analogue scale (VAS) of pain - unable to use patient-controlled analgesia (PCA) device - contraindications to spinal anesthesia or CFNB (coagulopathy, progressive neurological deficit, intracranial space occupying lesion, unstable hemodynamic state, local infection at site of injection and patient refusal) - allergy to any drugs used in this study - inadequate level of spinal anesthesia or CFNB - start case after 12.00 a.m.

Design outcomes

Primary

MeasureTime frame
48 hours postoperative morphine consumption 48 hours after the operation record morphine consumption by using PCA device in milligram

Secondary

MeasureTime frame
Postoperative morphine consumption during 0 - 4, 4 - 8, 8 - 24, 24 - 48 and 0 - 24 hours interval 0 - 4, 4 - 8, 8 - 24, 24 - 48 and 0 - 24 hours after the operation record morphine consumption by using PCA device in each time in milligram,Pain score at rest, 45 degree knee flexion, maximal knee flexion and sitting on the morning of POD1 on the morning of postoperative day 1 and postoperative day 2 record VAS in millimeter,Range of motion on the morning of POD1 and POD2 on the morning of postoperative day 1 and postoperative day 2 by using goniometer in degree,Side effects 48 hours after the operation using a questionnaire interview in yes or no

Countries

Thailand

Contacts

Public ContactPhetprapa Thongsrichan

Chaophraya Yommarat Hospital

phet@doramail.com+66847795925

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026